Rocket Pharmaceuticals, Inc. technical analysis
Technical analysis of Rocket Pharmaceuticals, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. is a late-stage biotechnology company that develops genetic therapies for rare and devastating diseases using in vivo adeno-associated viral (AAV) and ex vivo lentiviral (LV) technologies. Its development programs target inherited cardiac disorders and genetic diseases affecting the immune system and blood, with candidates at various stages from preclinical to clinical trials.
Description generated automatically from public sources; it may be inaccurate or out of date.
Rocket Pharmaceuticals, Inc.: latest session data
Closing values for September 3, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
3.59 $
+6.69%
50 sessions
3.54 $
+8.22%
200 sessions
3.57 $
+7.32%
Session levels
s2
3.60
Support
s1
3.73
Support
pivot
3.84
Pivot
r1
3.97
Resistance
r2
4.09
Resistance
How to read it
In the September 3, 2026 session Rocket Pharmaceuticals, Inc. closed lower at 3.83 $, −0.65% versus the previous session.
The price sits above every moving average observed: +6.69% against the 21-session average, +8.22% against the 50 and +7.32% against the 200.
The 14-period RSI reads 59.1, in neutral territory.
MACD stands at 0.101 against a signal line at 0.072: the histogram is positive (+0.029).
ADX reads 20.5, indicating weak directionality.
Levels computed on the latest session place supports at 3.73 and 3.60 $ and resistances at 3.97 and 4.09 $, around a pivot of 3.84.
The average daily range (ATR) is 0.210 $, or 5.47% of price.
Turnover was 152.7K shares, 12% of the 20-session average.
Over the last twelve months the price ranged between 2.53 and 5.14 $, and today stands −25.39% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the RCKT analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Rocket Pharmaceuticals, Inc.
How is Rocket Pharmaceuticals, Inc. analysed technically?
Technical analysis of Rocket Pharmaceuticals, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Rocket Pharmaceuticals, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Rocket Pharmaceuticals, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Rocket Pharmaceuticals, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.